(24/7 MARKET NEWS) – Trevena, Inc. (TRVN: NASDAQ) stated, this morning, that it received a $15 million tranche under its non-dilutive R-Bridge ex-US royalty-based financing, which was triggered by the first commercial sale of OLINVYK in China by Jiangsu Nhwa, the Company’s licensee in China.
Trevena is trading at $1.04, up $0.165 (+18.84%), on 345.01K premarket shares traded.
Its 52-week range is $0.58 to $5.575. It’s next resistance points are $1.06 and $1.12, and if it can break through those on strong trading volume it could break out the $1.40 level.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.